Spevigo 450 mg/7.5 mL (60 mg/mL) single-dose vial Images
Generic Name: spesolimab
This medication has been identified as Spevigo 450 mg/7.5 mL (60 mg/mL) single-dose vial. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.
Spevigo is used in the treatment of Generalized Pustular Psoriasis and belongs to the drug class interleukin inhibitors. Spevigo 450 mg/7.5 mL (60 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Spevigo
- Generic Name
- spesolimab
- Strength
- 450 mg/7.5 mL (60 mg/mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00597-0035
More about Spevigo (spesolimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.